Abstract
Conventional calcium sulfate bone cements suffer from rapid degradation, poor anti-washout property, and inadequate bioactivity. To overcome these limitations, we developed an injectable bone cement based on a novel ternary synergistic system of Sr-doped alginate-phosphate (SA/Sr/PO43-) and hydrothermally synthesized α-calcium sulfate hemihydrate (α-CSH). This design leverages the rapid physical crosslinking between Ca2+ from α-CSH and the guluronic acid/mannuronic acid blocks of sodium alginate, resulting in a reinforced network with enhanced initial anti-washout property and a wet compressive strength of 2-12 MPa. Simultaneously, the alginate matrix induces the in situ mineralization of Ca2+ and PO43- ions, forming a calcium-deficient hydroxyapatite (CDHA) precursor that decelerates the degradation rate (18% in PBS over 60 days) to match new bone formation. In addition, strontium ions (Sr2+) sustainably released from the material promote in vitro osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). This work presents a novel composite cement that successfully integrates injectability, robust mechanical properties, controllable degradation, and osteoinductive capability.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
